We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Paula J. Bretz
Paula J. Bretz
Products
PRODUCTS
Mylan Pharmaceuticals, Inc.
Paula J. Bretz
,
Jonathan Chapman
, and
Brooke K. Higgins
Price:
$117.00
View
Afton Scientific Corp.
Paula J. Bretz
and
Brooke K. Higgins
Price:
$117.00
View
Mylan Pharmaceuticals, Inc.
Paula J. Bretz
and
William A. Warnick
Price:
$117.00
View
Upcoming Events
08
Feb
Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions
09
Feb
The Inextricable Link Between Data Integrity and Quality Culture
15
Feb
Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis
16
Feb
Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success
22
Feb
Best Practices for Developing and Maintaining a GxP Training Matrix
07
Mar
FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
BioVentrix gets Expanded Access Approval for Left Ventricle Support System
FDA Approves Stemline’s Orserdu for Several Forms of Breast Cancer
FDA Issues Update on LivaNova Recall of Blood Pumping System
EU Expands Dupixent’s Authorization to Include Eosinophilic Esophagitis
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
